SANTA ANA, Calif. (AP) — Los Angeles Angels outfielder Mike Trout is planning to testify Tuesday in a lawsuit over whether the MLB team should be held responsible for the drug overdose death of pitcher Tyler Skaggs.

Trout, a three-time American League most valuable player who hit his 400th career home run this year, is expected to take the stand in a Southern California courtroom and speak about his friendship with Skaggs, who died on a team trip to Texas in 2019 after taking a fentanyl-laced pill he got from Angels communication director Eric Kay. Trout could also be asked about what he knew of Kay's drug use at the time.

Recommended for you

Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Recommended for you

(0) comments

Welcome to the discussion.

Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.

Thank you for visiting the Daily Journal.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account.

We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.

A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!

Want to join the discussion?

Only subscribers can view and post comments on articles.

Already a subscriber? Login Here